|
CMR Pattern
| | |
P = 0.094
|
2.16 (0.86–5.38)
|
|
Nodular
|
13
|
137
| | |
|
Linear
|
9
|
44
| | |
|
Wall distribution
| | |
P = 0.103
| |
|
Subepicardial
|
15
|
153
| | |
|
Midwall
|
7
|
26
| | |
|
Transmural
|
0
|
2
| | |
|
Localization
| | |
P = 0.65
| |
|
Posterolateral
|
13
|
109
| | |
|
Septal
|
1
|
2
| | |
|
Anterior
|
2
|
15
| | |
|
Septal + posterolateral
|
6
|
54
| | |
|
Presence of pericardial effusion
|
9
|
49
|
P = 0.18
|
1.86 (0.75–4.64)
|
|
Gender
| | |
P = 0.87
| |
|
Male
|
137
|
17
| | |
|
Female
|
44
|
5
| | |
|
Presence and extent of Early Gadolinium Enhancement (% myocardial surface area)
|
2.2 % ± 4.1
|
5.1 % ± 6.0
|
P = 0.005
| |
|
Number of segments with EGE
|
1.0 ± 1.7
|
1.9 ± 1.9
|
P = 0.04
| |
|
Age
|
47 ± 13
|
42 ± 17
|
P = 0.14
|
0.91 (0.32–2.62)
|
|
Presence of asynergic segments on CMR
|
6
|
33
|
P = 0.31
|
1.68 (0.61–4.62)
|
|
Presence of EGE in 2 opposed walls
|
3
|
27
|
P = 0.87
|
0.90 (0.25–3.25)
|
|
Presence of LGE in 2 opposed walls
|
8
|
69
|
P = 0.87
|
0.93 (0.37–2.32)
|
|
Myocardial extent of Late Gadolinium Enhancement (% myocardial surface area)
|
11.9 % ± 6.8
|
11.3 % ± 7.2
|
P = 0.72
| |
|
Number of segments with LGE
|
4.2 ± 2.4
|
3.7 ± 2.2
|
P = 0.41
| |
|
Presence of T2-hypersignal
|
8
|
92
|
P = 0.69
|
0.81 (0.27–2.46)
|
|
Presence of T2-hypersignal in opposed walls
|
2
|
32
|
P = 0.50
|
0.59 (0.13–2.79)
|
|
Myocardial extent of hyper T2 signal (% myocardial surface area)
|
4.9 ± 4.9
|
7.0 ± 7.0
|
P = 0.16
| |
|
Number of segments with hyper T2 signal
|
1.9 ± 1.8
|
1.9 ± 1.9
|
P = 0.9
| |
|
Initial end-diastolic LV volume, ml/m2
|
77 ± 22
|
73 ± 18
|
P = 0.39
| |
|
Initial LV ejection fraction, %
|
51.9 ± 9
|
57.6 ± 8.9
|
P = 0.009
| |
